🇺🇸 FDA

Intelligence · Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs · EMA approved · by data quality · Page 34 of 39

  1. olopatadine

    OPATANOL

    EMA: approved

    S01GX09

  2. omalizumab

    OMLYCLO Novartis Pharmaceuticals

    FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    R03DX05

  3. onasemnogene abeparvovec

    ZOLGENSMA Novartis Pharmaceuticals

    EMA: approved · TGA: approved

    M09AX09

  4. oritavancin

    TENKASI (PREVIOUSLY ORBACTIV)

    EMA: approved

    J01XA05

  5. oseltamivir

    EBILFUMIN

    EMA: approved · NMPA: clinical trials

    J05AH02

  6. osilodrostat

    ISTURISA Recordati Rare Diseases Australia Pty.

    EMA: approved · TGA: approved

    H02CA02

  7. osimertinib

    TAGRISSO AstraZeneca

    EMA: approved · TGA: approved · NMPA: clinical trials

    L01XE

  8. ozanimod

    ZEPOSIA Bristol-Myers Squibb Australia Pty Ltd

    FDA: approved · EMA: approved · TGA: approved

    L04AA38

  9. padeliporfin

    TOOKAD

    EMA: approved

    L01XD07

  10. palivizumab

    SYNAGIS

    FDA: approved · EMA: approved

    J06BD01

  11. palonosetron

    PALONOSETRON DR.REDDY''S Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    A04AA05

  12. pandemic influenza vaccine (h5n1) (live attenuated, nasal)

    PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)

    EMA: approved

    J07BB03

  13. pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS)

    EMA: approved

    J07BB02

  14. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    FOCLIVIA

    EMA: approved

    J07BB02

  15. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)

    INCELLIPAN

    EMA: approved

    J07BB02

  16. panobinostat

    FARYDAK

    EMA: approved

    L01XH03

  17. parecoxib

    DYNASTAT

    EMA: approved

    M01AH04

  18. pasireotide

    SIGNIFOR

    EMA: approved

    H01CB05

  19. patiromer

    VELTASSA Seqirus (Australia) Pty Ltd

    EMA: approved · TGA: approved

    V03AE09

  20. pazopanib

    PAZOPANIB ADVZ Novartis Pharmaceuticals

    EMA: approved · TGA: approved

    L01XE11

  21. pegaspargase

    ONCASPAR

    FDA: approved · EMA: approved

    L01XX24

  22. pegfilgrastim

    PELGRAZ Accord Healthcare Pty.

    FDA: approved · EMA: approved · TGA: approved

    L03AA13

  23. pegunigalsidase alfa

    ELFABRIO

    EMA: approved

    A16AB20

  24. pegzilarginase

    LOARGYS

    EMA: approved

    A16AB24

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.